Please ensure Javascript is enabled for purposes of website accessibility

Monsanto Rounds Up Uncertainty

By Brian Orelli, PhD – Updated Apr 6, 2017 at 11:48AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When will the dust settle?

One line in Monsanto's (NYSE: MON) earnings report tells the whole story: Gross profit margins in its third fiscal quarter plummeted from 58% last year to 47% this year.

Welcome to the wonderful world of generics.

Gross profit on the company's Roundup business was actually negative this quarter. That's right, the company had to pay $189 million for the privilege of selling the herbicide. Some of that cost came from a restructuring charge as the company repositioned Roundup to compete with low-priced generics, but it's going to have to get a better read on farmers' needs if it's going to continue in the now low-margin business.

Management hopes the restructuring will help bring everything into an equilibrium, but without the ability to control the competition, I'm not sure how much Monsanto will be able to control the oversupply/undersupply cycle. Despite the efforts of Canpotex (the Canadian potash alliance), fertilizer producers have the same problem, with Mosaic (NYSE: MOS), PotashCorp (NYSE: POT), Agrium (NYSE: AGU), and the like recently experiencing their own feast or famine cycles.

Monsanto's seed trait business is more stable, but it didn't help gross margins as much as it could. A restructuring charge and added costs from launching new products caused gross margins for those products to slip as well. The good news is seed sales were still up 5%. Even if the company wasn't able to capture all the added revenue as profit, at least it's competing well against offerings from DuPont (NYSE: DD), Dow Chemical (NYSE: DOW), and Syngenta (NYSE: SYT). Margins should get a bump back up once the launch is over.

Shares slipped more than 1% yesterday, although they were down considerably more earlier in the day. It's tough to blame the quarterly results for the share decline since the dismal performance was expected. The company slashed guidance in May and actually beat the lowered range by $0.01.

Instead, I think the decline comes from investors' uncertainty about the future. Management isn't sure if the company will stay profitable or swing to a loss in its last fiscal quarter of 2010. More importantly, how much can we trust management's expectation of mid-teens growth in earnings once the generic-Roundup dust settles?

Buying shares in the midst of a transition could be very profitable, but cautious investors will want to wait until the company proves itself before investing.

Monsanto is a recommendation of the Motley Fool Inside Value newsletter. If you're interested in picking through the wreckage for possible turnaround candidates, you should have the Inside Value team on your side. Check it out for free with a 30-day trial

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. Syngenta is a Motley Fool Global Gains recommendation. Motley Fool Options has recommended a synthetic long position on Monsanto. The Fool's disclosure policy is all the certainty you need.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Monsanto Company Stock Quote
Monsanto Company
MON
Nutrien Stock Quote
Nutrien
POT
E. I. du Pont de Nemours and Company Stock Quote
E. I. du Pont de Nemours and Company
DD
DuPont de Nemours, Inc. Stock Quote
DuPont de Nemours, Inc.
DOW
The Mosaic Company Stock Quote
The Mosaic Company
MOS
$48.53 (-7.60%) $-3.99

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.